• Noninvasive body contouring devices vary by efficacy, treatment schedule and safety profile. • This review compares body contouring modalities, allowing for quick comparison between modalities. • This review enables the selection of a body contouring modality that best suits each specific patient's goals, availability and aversion to risk.
Cosmetic procedures targeting excess fat have evolved over the past 30 years to be less invasive. Unfortunately, objective studies comparing modalities for noninvasive body contouring are limited, which hampers physicians and patients alike when choosing an appropriate treatment device. There are four major modalities for noninvasive body sculpting: cryolipolysis (Cryo), radiofrequency (RF), focused ultrasound (FUS) and low level laser therapy (LLLT) 1-7 . FUS is subdivided into high intensity focused ultrasound (HIFU) and low intensity focused ultrasound (LOFU). Each modality varies by treatment schedule, onset of results, and side effect profile. Furthermore, results are reported in multiple ways, from circumference measurements to diagnostic ultrasound of fat thickness. This review of the published peer-reviewed literature presents and summarizes the objective data of the four major noninvasive modalities for comparison.
In October of 2016, a pubmed search was performed with terms "noninvasive body contouring" and "non-invasive body contouring." The search was limited to human studies in English. The scope was limited to objective data reported on Cryo, FUS, RF and LLLT. A total of 58 articles were found, the abstracts were screened, and all remaining articles were thoroughly read. Pertinent sources cited by these articles were also obtained and read. 55 articles were within scope and reported data from 3649 patients ( Table 1) . The modality with the least total study participants was RF (280 patients, 10 studies). The most studied modality was Cryo (1407 patients, 15 studies).
Decreased localized abdominal/flank adiposity was the most consistently reported outcome across all studies, with minimum (1.4cm) 8 and maximum (7.4cm) 9 decreases both reported by RF studies (Figure 1 ). Cryo did not report results using girth as a metric but reported 19.6-25.5% decreased abdominal/flank fat thickness when measured by ultrasound [10] [11] . One RF study reported 29% decreased abdominal/flank fat thickness by ultrasound 8 . Two studies reported results that were not statistically significant, one using FUS 12 and the other using LLLT 13 . Almost all reported side effects were mild and transient. The most commonly reported side effect was pain (often reported as patient comfort). No pain was reported in all LLLT studies and 2 studies evaluating RF [14] [15] ( Figure 2 ). Side effects were most common with Cryo, followed by RF and FUS. To avoid side effects, comparable results were often obtained via multiple, lower energy treatments. Reported patient satisfaction rates varied by modality ( Figure 3 ) and body location.
The one non-transient side effect reported was paradoxical adipose hyperplasia (PAH) associated with Cryo. This rare adverse event was reported 4 times in the articles reviewed [16] [17] . Some estimates of incidence are 1:20,000 16 but may be as high as 1:200 17 . 18 , while other modalities are associated with progressive, cumulative results. To further guide appropriate modality selection, each modality will be assessed below.
FUS
Subdivisions of FUS are HIFU (thermal lipolysis) and LOFU (mechanical cavitation) [19] [20] .
HIFU was studied via Liposonix (Solta) [21] [22] [23] [24] [25] , with reported results within 4 weeks of a single treatment [23] [24] . Each treatment took under an hour and multiple passes were delivered over a localized area. The HIFU device was studied on the abdomen and flank only ( Figure 4) . Redness, pain, swelling, and bruising were common side effects with treatment. Altered sensation and formation of subcutaneous nodules were found in some patients, but all reported side effects were transient.
LOFU was studied primarily via UltraShape Contour I (Syneron/Candela) [26] [27] [28] [29] . Results were seen as early as 2 weeks 26, 29 but 3 treatments were typically performed. Each treatment session took 30-90 minutes, depending on the area(s) targeted. The device was studied on the abdomen 26, 28-29 , flanks 26, 28-29 , thighs [28] [29] , knees 28 and chest/breast 28 . Figure 5 summarizes LOFU results on the waist. The most common side effects were redness and pain. Rarely, blisters and bruising occurred. In particular, LOFU penetrates deeper than HIFU and superficial bones (iliac crest) may reflect energy and cause blisters 12 . For this reason, caution should be used over areas with superficial bony structures. In addition, one study with a high dropout rate (only 11/53 subjects returned for follow-up evaluation) failed to find statistically significant results. The lack of follow-up may have significantly decreased the study's power 12 .
RF
Many RF devices have been studied to date and review articles specific to RF have been published [31] [32] [33] [34] . The VelaShape (Syneron/Candela) [8] [9] 35 , 3DEEP (Endymed) 14, 15 , Vanquish (BTL) [36] [37] , ThermiSmooth 250 (Thermi/Almirall) 38 and TriPollar (Pollogen/Lumenis) [39] [40] systems all had objective, clinical data on humans. Treatment regimens were similar amongst them but results were variable, which may be due to the small sample of patients studied.
Onset was appreciable within a week 14 but multiple treatments were often performed. The abdomen 8-9, 14-15, 35-37, 40 , flanks 8-9, 14-15, 35-37, 40 , buttocks [8] [9] 40 , thighs 8-9, 14, 39-40 , arms 35 and face 32 were all studied with RF for body contouring. Reported RF results on abdominal girth are presented in Figure 6 . Transient redness and swelling were expected side effects, with most studies reporting both in 100% of patients. VelaShape had some reports of bruising and burns as well [8] [9] 35 .
Cryo
The main Cryo device investigated was CoolSculpting (Zeltiq) 10-11, 18, 41-54 , which has also had review articles published specific to the modality [41] [42] [43] . Only one treatment was usually necessary but diminishing returns with additional treatments were reported 18 and onset took about 8 weeks 11, 44 . In addition to the abdomen 10, 18, [45] [46] , flank 10-11, 18, 44-48 , buttocks 45 and back 10, [45] [46] , specific applicators exist for the arms 50 , knees 10, 45 and thighs 10, [45] [46] [49] [50] [51] [52] tended to exceed those of the extremities 10, 45 (Figures 7, 8, 9 ). Redness, swelling, tissue infiltration and mild pain were expected transient side effects, while bruising was much less common. Almost all patients experienced some degree of altered sensation after treatment. Most were limited to numbness but the effects lingered up to 6 weeks 11 . Unfortunately, there were some reports of PAH, which is thought to be permanent and occurred 2-12 months after treatment [16] [17] . The incidence of PAH is estimated to be 1:20,000 treated patients 16 but may be as high as 1:200 17 and may occur in higher proportions of men 16 . Over 30 cases have been reported to date.
LLLT
LLLT has been separately reviewed as a modality 53 and was investigated via Zerona (Erchonia) [54] [55] [56] [57] [58] [59] [60] and Lapex 2000 (Meridian) 61 . Treatments were studied on the abdomen 54 61 . While the results were modest compared to other modalities ( Figure 10 ), there were absolutely no side effects reported. However, one study 55 failed to report significant results. It was noted that the study was very small (only 5 patients) and was only applied to partial body sites. Since LLLT may involve mobilizing released fat for systemic metabolism, broader application of the laser light may be relevant. Furthermore, Jackson et al 57 reported decreases in girth at untreated sites, supporting a systemic mechanism. Still, the study was retrospective and those patients that volunteered to share their experience are may be those with superior results.
Combinations
Combination devices are available, two of which were investigated. UltraShape RFVac (Syneron/Candela) 62 While it is possible that the diminishing returns of Cryo could be mitigated by additional, simultaneously applied modalities, the small sample size must be taken into account and further studies should be completed for confirmation.
Limitations
Variability of reported endpoints was the main limitation. Comparing circumference measurements to ultrasound or caliper measurements was not straight forward 65 . Some endpoints combined multiple treatment areas into a single large measurement, which may include bilateral areas or the summation of multiple, distinct treatment areas. Flank results were grouped with the abdomen or back, depending on the study. The waist or hips represented any combination of the abdomen, back and/or flanks.
Additional problems existed with variability in study protocols. Not all studies required patients to abstain from diet and exercise and those that did tracked weight changes as a marker of compliance. Unfortunately, small fluctuations in weight could correspond to unpredictable changes in body contour.
Another limitation was the high percentage of retrospective study patients (53%).
Retrospective studies tended to report better results and may underestimate complications due to selection bias.
This study is also limited by scope and search terms. There are more devices than those described in this review that have been studied by other means.
Nevertheless, patients and physicians don't necessarily need to be precise and accurate when it comes to body contouring. Ultimately, patients and physicians are looking for improvement in body contour without significant risk. As such, patient satisfaction and paucity of side effects may be more important than clear cut, drastic results. If such results are desired, abdominoplasty and liposuction are options.
Future Studies/Devices
A formal meta-analysis is needed for each modality so results can be combined and compared.
The field of noninvasive body contouring is growing and many new devices are on the horizon. One recently introduced device is SculpSure (Cynosure). SculpSure is a new type of laser, which reportedly causes lipolysis rather than inducing transient micropores in adipocytes. Well-designed multi-center studies will be required to evaluate this (and other) new technology, so that patients and clinicians can optimize results.
Noninvasive body contouring is a growing field, projected to accrue more objective, peer-reviewed data with each passing year. While modalities vary by mechanism and side effects, reductions of localized adiposity are generally mild but clinically and statistically significant. Not unsurprisingly, the modalities with the least risky side effect profiles were associated with the most modest reductions in localized fat. While it is unlikely that noninvasive devices will ever rival their surgically invasive counterparts, it is equally apparent that the side effect profiles of noninvasive procedures are likely to remain superior to invasive surgery. Most importantly, patients and physicians must discuss specific goals, both long term and short term, when deciding the best course of treatment for body contouring. To date, reported positive results for noninvasive body contouring have been most noticeable via RF while LLLT has reported the lowest risk of side effects.
